|
Jul 25
|
scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease
|
|
Jul 24
|
When Will scPharmaceuticals Inc. (NASDAQ:SCPH) Breakeven?
|
|
Jun 5
|
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
|
|
Jun 5
|
Increases to scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Might Cool off for now
|
|
Oct 19
|
Those who invested in scPharmaceuticals (NASDAQ:SCPH) five years ago are up 47%
|
|
Aug 10
|
ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 10
|
scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
|